ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107 | +25.9% | 4,018 | +65.4% | 0.00% | – |
| Q2 2023 | $85 | -9.6% | 2,429 | -34.6% | 0.00% | – |
| Q1 2023 | $94 | -26.0% | 3,713 | +18.0% | 0.00% | – |
| Q4 2022 | $127 | -99.9% | 3,147 | -17.4% | 0.00% | – |
| Q3 2022 | $125,000 | -6.0% | 3,811 | +0.2% | 0.00% | – |
| Q2 2022 | $133,000 | +52.9% | 3,804 | +97.4% | 0.00% | – |
| Q1 2022 | $87,000 | -5.4% | 1,927 | +37.3% | 0.00% | – |
| Q4 2021 | $92,000 | -94.5% | 1,403 | -94.8% | 0.00% | -100.0% |
| Q3 2021 | $1,675,000 | +701.4% | 26,847 | +961.1% | 0.00% | – |
| Q2 2021 | $209,000 | +10350.0% | 2,530 | +6737.8% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -95.7% | 37 | -95.1% | 0.00% | – |
| Q4 2019 | $47,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |